--- title: "12 Health Care Stocks Moving In Friday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/275930262.md" description: "In Friday's trading session, several health care stocks experienced significant movements. American Well (AMWL) surged 31.2% to $5.68, while Phio Pharma (PHIO) rose 28.68% to $1.57. Other gainers included Immunic (IMUX) up 27.57%, Cypherpunk Technologies (CYPH) up 21.12%, and Oncolytics Biotech (ONCY) up 18.59%. Conversely, Intensity Therapeutics (INTS) fell 26.3% to $0.27, Geovax Labs (GOVX) dropped 23.85% to $1.76, and Upstream Bio (UPB) decreased 21.22% to $10.09. Overall, the market showed volatility among health care stocks following Q4 earnings announcements." datetime: "2026-02-13T17:05:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275930262.md) - [en](https://longbridge.com/en/news/275930262.md) - [zh-HK](https://longbridge.com/zh-HK/news/275930262.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275930262.md) | [繁體中文](https://longbridge.com/zh-HK/news/275930262.md) # 12 Health Care Stocks Moving In Friday's Intraday Session ### Gainers - **American Well** (NYSE:AMWL) stock moved upwards by 31.2% to $5.68 during Friday's regular session. The market value of their outstanding shares is at $68.4 million. The company's, Q4 earnings came out yesterday. - **Phio Pharma** (NASDAQ:PHIO) stock increased by 28.68% to $1.57. The market value of their outstanding shares is at $13.1 million. - **Immunic** (NASDAQ:IMUX) shares rose 27.57% to $1.11. The company's market cap stands at $104.6 million. - **Cypherpunk Technologies** (NASDAQ:CYPH) stock rose 21.12% to $0.73. The company's market cap stands at $33.9 million. - **Oncolytics Biotech** (NASDAQ:ONCY) shares increased by 18.59% to $0.99. The market value of their outstanding shares is at $89.8 million. - **CASI Pharmaceuticals** (NASDAQ:CASI) shares rose 17.59% to $0.88. The market value of their outstanding shares is at $11.5 million. ### Losers - **Intensity Therapeutics** (NASDAQ:INTS) shares fell 26.3% to $0.27 during Friday's regular session. The market value of their outstanding shares is at $22.2 million. - **Geovax Labs** (NASDAQ:GOVX) shares fell 23.85% to $1.76. The market value of their outstanding shares is at $4.0 million. - **Upstream Bio** (NASDAQ:UPB) shares fell 21.22% to $10.09. The market value of their outstanding shares is at $691.6 million. - **OKYO Pharma** (NASDAQ:OKYO) stock decreased by 20.51% to $1.73. The market value of their outstanding shares is at $88.0 million. - **Sensus Healthcare** (NASDAQ:SRTS) stock decreased by 18.18% to $3.81. The market value of their outstanding shares is at $76.3 million. As per the press release, Q4 earnings came out yesterday. - **Polaryx Therapeutics** (NASDAQ:PLYX) stock decreased by 16.1% to $2.45. The company's market cap stands at $138.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md) - [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md) - [Intensity Therapeutics, Inc. (INTS.US)](https://longbridge.com/en/quote/INTS.US.md) - [Upstream Bio, Inc. (UPB.US)](https://longbridge.com/en/quote/UPB.US.md) - [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md) - [Phio Pharmaceuticals Corp. (PHIO.US)](https://longbridge.com/en/quote/PHIO.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md) - [GeoVax Labs, Inc. (GOVX.US)](https://longbridge.com/en/quote/GOVX.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md) - [Immunic, Inc. (IMUX.US)](https://longbridge.com/en/quote/IMUX.US.md) - [iShares US Healthcare Providers ETF (IHF.US)](https://longbridge.com/en/quote/IHF.US.md) - [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md) - [American Well Corporation (AMWL.US)](https://longbridge.com/en/quote/AMWL.US.md) - [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md) - [Stt Strt® SPDR® S&P®HlthCrSvcsETF (XHS.US)](https://longbridge.com/en/quote/XHS.US.md) - [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md) - [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md) - [Oncolytics Biotech Inc. (ONCY.US)](https://longbridge.com/en/quote/ONCY.US.md) - [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md) - [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md) - [Cypherpunk Technologies Inc. (CYPH.US)](https://longbridge.com/en/quote/CYPH.US.md) ## Related News & Research - [Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study | INTS Stock News](https://longbridge.com/en/news/278874097.md) - [Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/279226861.md) - [HealthTrust Advances the Future of Clinically Aligned Performance at 2026 FAH Conference](https://longbridge.com/en/news/278743138.md) - [Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis | ACRS Stock News](https://longbridge.com/en/news/279581540.md) - [Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany](https://longbridge.com/en/news/279232104.md)